$AEYE

Audioeye, Inc. (NASDAQ:AEYE) Sees Significant Growth in Short Interest

Audioeye, Inc. (NASDAQ:AEYE) experienced a significant 17.5% increase in short interest, reaching 744,169 shares as of April 15th, representing 8.4% of outstanding shares. Despite this, analysts maintain a "Moderate Buy" consensus rating with an average target price of $14.63. The company recently surpassed Q1 earnings and revenue estimates and provided positive FY2026 guidance.

Original reporting
MarketBeat · MarketBeat
Published Apr 30, 2026, 5:25 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 30, 2026, 7:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Audioeye, Inc. (NASDAQ:AEYE) Sees Significant Growth in Short Interest — source image
Decision brief

The 30-second read

$AEYENeutralMed
01

Why it matters

The increased short interest may signal trader skepticism, but strong fundamentals suggest the company remains on a growth trajectory.

02

Market read

The news is relevant for traders focusing on tech stocks and short interest dynamics, with potential for short-term trading opportunities.

03

What to watch

Market-wide liquidity conditions and macroeconomic factors could influence stock performance independently of company-specific news.

Timing: short-term (next 1-4 weeks)

Background

Audioeye, Inc. reported surpassing Q1 earnings and revenue estimates, with positive FY2026 guidance, amid a notable increase in short interest.

Company-level read

Ticker impact

$AEYENeutralMedium confidence
Context

The news about increased short interest and positive earnings guidance directly impacts Audioeye, Inc.

Expected impact

Potential short-term volatility with a slight upward bias due to positive earnings outlook; long-term trend remains uncertain.

Evidence & confidence

The positive earnings and guidance support bullish sentiment, but increased short interest indicates some traders expect a correction or are hedging against potential downside.

Market effects

The technology and financial markets sectors may experience increased activity due to earnings reports and short interest changes.

Limited regional impact; primarily affecting US-based tech and financial stocks.

Moderate; reflects broader market sentiment towards tech stocks and short interest dynamics.

Counterpoint

The rise in short interest indicates potential underlying concerns about the company's long-term prospects, and a correction could occur if earnings guidance fails to materialize.

Key entities

  • Audioeye, Inc.

    A provider of digital accessibility solutions listed on NASDAQ.

Related articles

$AEYEMed

AudioEye (AEYE) Q2 2026 Earnings Call Transcript

AudioEye reported Q2 2026 revenue of $10.7M, up 9% YoY, with adjusted EBITDA of $3M, a 54% increase. ARR reached $42.3M, up 11% sequentially. The company raised full-year adjusted EBITDA guidance to at least $12.7M and adjusted EPS to at least $0.98. Management highlighted growth in enterprise ARR and partner revenue, while noting risks from AI-driven accessibility issues and shifting legal risks to interior web pages.

$AEYEMed

Audioeye Q2 Earnings Call Highlights

AudioEye (NASDAQ:AEYE) reported Q2 net loss of $900,000, or $0.07/share, versus breakeven a year earlier, when a $1.4 million contingent consideration revaluation boosted results. Adjusted free cash flow was $2.6 million. Full-year adjusted EBITDA guidance rose to at least $12.7 million; revenue midpoint held at $43.5-$44.0 million. Q3 revenue forecast: $10.85-$11.05 million.

$AEYEHighAI 9/10

AudioEye Reports Record Second Quarter 2026 Results

AudioEye (Nasdaq: AEYE) reported Q2 2026 results for the quarter ended June 30, 2026. ARR rose to $42.3M from $41.2M sequentially and 11% YoY. Revenue increased 9% to $10.7M. Adjusted EBITDA was $3.0M. The company raised full-year adjusted EBITDA guidance and expects Q3 revenue $10.85M-$11.05M.

$AEYEMed

AUDIOEYE INC (AEYE): Results of Operations and Financial Condition

AUDIOEYE INC (AEYE) filed an SEC Form 8-K — Results of Operations and Financial Condition. ​ ​ Exhibit 99.1 ​ AudioEye Reports Record Second Quarter 2026 Results Forty-Second Consecutive Period of Record Revenue TUCSON, Ariz. — August 13, 2026 — AudioEye, Inc. (Nasdaq: AEYE) (“AudioEye” or the “Company”) , an industry-leading digital accessibility company, reported fin

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.